2023 A review in eye care

 

As many of you know 2023 was a year of big change for me. Eyegotcha became part of Vision Source Bridgeville in February.

In general, there were several big events in 2023 in regard to eye care. The FDA approved 11 new drugs:

• Pegcetacoplan is a medication approved for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration.
• Izcrvay also for GA
•  Aflibercept used to treat preterm infants, diagnosed with ROP
• Regeneron also received approval for Aflibercept eight MG injection for the treatment of wet Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Diabetic Retinopathy.
• Faricimab- SVOR for treatment of retinal vein occlusion
• Mydcombi the first ophthalmology spray for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. It marks the first approved fixed-dose combination of tropicamide and phenylephrine in the U.S.
• MIEBO for treatment of dry eye disease
•  Vevye also received approval for the treatment of dry eye disease
• Xdemvy the first and only treatment for Demodex Blepharitis
• Ryzumi was approved for the reversal of pharmacology-induced mydriasis
• Pilocarpine hydrochloride for treatment of presbyopia in adults

Most of these treatments are not available for general use. It sometimes takes days to months to go from FDA approval until the drug launches. Supply chain issues, manufacturing, and more trials will determine when these treatments hit the market.

The FDA monitors the whole process, including marketing the new products.

Other big news in 2023:

• The ongoing eyedrop recall of over-the-counter store branded eyedrops
•  Advancements in LASIK surgery technology
• The world saw the first whole, eye transplant in a human being.
• The fashion of eyewear has advanced with the use of new materials and designs
•  Artificial intelligence (AI) and eye care is gaining momentum. AI algorithms can help predict risks for conditions and diseases
• Smart glasses and virtual headsets. Advances in wearable technology is leading the way to provide visually impaired patients with more freedom.
• Retinal gene therapy is a non-invasive treatment for eye diseases, where a virus containing a healthy copy of the gene that causes the disease is then injected into the eye.

Expectations for 2024 are that eye care sector will continue to evolve and grow. With more new technologies will be created, new drugs will go on to clinical trials and lead to approvals, and one of the biggest issues that will continue to be addressed in vision care is the access to visual health for all.

Sources:

www.optometrytimes.com

www.artofoptics.com

www.usatoday.com

#visionsourcesouthhills

#DrClaudiaWendel

#PittsburghOptometrist

#PittsburghEyeCare

Did you know? Pittsburgh Christmas Trivia

1. Bing Crosby, singer of White Christmas, had a 25% ownership of the Pittsburgh Pirates until he passed away in 1977.

2. Farkleberry tarts were sold by KDKA radio morning DJ Jack Bogut as a fundraiser for Children’s Hospital in the early 1970s during the Christmas season.

3. Since 1953, the lighting of the Horne's tree has signified the beginning of the holiday season in Pittsburgh. The 100-foot-tall Christmas tree goes up on the corner of the old Joseph Horne's Department store building at Penn Avenue and Stanwix Street.

4. Pittsburgh has only had a white Christmas 14% of the time since 1870 when records on weather have been kept. For Christmas to be considered "white," an inch of snow must fall on Dec. 25.

5. Gimbals Department store’s talking tree, Trinna really had a live person inside speaking to children as they walked by.

6. Jay Livingston, one of the writers of the song Silver Bells was from the Pittsburgh area. 

#ChristmasInPittsburgh

#visionsourcesouthhills

#DrClaudiaWendel

#PittsburghOptometrist

#PittsburghEyeCare

 

2023 Eye Drop Recall is Expanding

 

Earlier this year, in April, I posted about a nationwide recall of eye drops, by the Food and Drug Administration (FDA). The FDA has now expanded its list of eye drops recalled this year. These recalled products could be tainted with bacteria.

The FDA says the eye drops are marketed under retailers and brands at Walmart, CVS, Rite-Aid, Target, Up & Up, Leader Rugby, and Velocity Pharma. The FDA is warning consumers to at once stop using 27 over-the-counter eye drop products.

Since April's post:

In May the Centers for Disease Control (CDC) noted that 81 patients in 18 states contracted a rare strain of drug-resistant Pseudomonas aeruginosa.

In August the FDA issued a warning to the public to immediately quit using Dr. Bernie's MSM drops due to bacterial and fungal contamination. The drops also contain methylsulfonylmethane (MSM), an ingredient not approved for use in the eyes.

In October and November, more eye drops were added to the FDA list of recalled eyedrops

The complete FDA list of recalled products can be found here. 

#visionsourcesouthhills

#DrClaudiaWendel

#PittsburghOptometrist

#PittsburghEyeCare

Sources:

www.cbsnews.com

www.prevention.com

www.USAToday.com

First Whole, Eye Transplant in a Human

 

The patient who received the transplant was Aaron James from Arkansas, a power company linesman. He suffered a work-related, high-voltage, electrical accident in June of 2021, that damaged the left side of his face, nose, mouth, and eye.

The transplant surgery was done six months ago, on May 27, 2023. The transplant surgery took 21 hours at New York University, Langone Health.

The whole eye transplant may only provide cosmetic benefits, this is a remarkable achievement. The surgery opens the possibility of restoring the appearance, and even sight after a disfiguring accident like the one that happened to Mr. James. Medicine is on the verge of being able to achieve eye transplants and vision restoration also transplanted were the eye socket and the eyelid. This transplant is the first attempt at injecting adult stem cells into a human optic nerve to try to regenerate it.

James’ transplanted eye does not have any sight now. However, his transplanted eye has shown remarkable signs of health. Normal ocular pressure, direct blood flow and oxygen to the retina, and may be capable of transmitting signals to the brain. It is still unknown whether James will eventually regain sight.

Sources:

www.reuters.com

www.langone.org

www.scientificamerican.com

www.NBCNewYork.com

#visionsourcesouthhills

#DrClaudiaWendel

#PittsburghOptometrist

#PittsburghEyeCare